Home Cart 0 Sign in  
X

[ CAS No. 38749-79-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 38749-79-0
Chemical Structure| 38749-79-0
Chemical Structure| 38749-79-0
Structure of 38749-79-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 38749-79-0 ]

Related Doc. of [ 38749-79-0 ]

Alternatived Products of [ 38749-79-0 ]

Product Details of [ 38749-79-0 ]

CAS No. :38749-79-0 MDL No. :MFCD00191224
Formula : C6H6BrN Boiling Point : -
Linear Structure Formula :- InChI Key :AIPWPTPHMIYYOX-UHFFFAOYSA-N
M.W : 172.02 Pubchem ID :1201003
Synonyms :

Calculated chemistry of [ 38749-79-0 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.9
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.97 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : 1.94
Log Po/w (WLOGP) : 2.15
Log Po/w (MLOGP) : 1.58
Log Po/w (SILICOS-IT) : 2.54
Consensus Log Po/w : 2.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.68
Solubility : 0.356 mg/ml ; 0.00207 mol/l
Class : Soluble
Log S (Ali) : -1.84
Solubility : 2.52 mg/ml ; 0.0146 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.26
Solubility : 0.0948 mg/ml ; 0.000551 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.2

Safety of [ 38749-79-0 ]

Signal Word:Danger Class:N/A
Precautionary Statements:P261-P264-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H318-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38749-79-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38749-79-0 ]
  • Downstream synthetic route of [ 38749-79-0 ]

[ 38749-79-0 ] Synthesis Path-Upstream   1~20

  • 1
  • [ 109-06-8 ]
  • [ 3430-13-5 ]
  • [ 38749-79-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 5, p. 871 - 880
[2] Journal of Labelled Compounds and Radiopharmaceuticals, 2006, vol. 49, # 9, p. 789 - 799
  • 2
  • [ 68-12-2 ]
  • [ 38749-79-0 ]
  • [ 60032-57-7 ]
YieldReaction ConditionsOperation in experiment
31%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at -78℃; for 1 h;
To a solution of 3-bromo-2-methylpyridine (148; 10 g, 58.1 mmol) in THF (150 mL) was added n-BuLi (2.5 M, 25.6 mL) at -78 °C. The reaction mixture was stirred at this temperature for Ih. DMF (1.30 mL) was then added and the resulting reaction mixture was stirred for 1 h at -78 0C. The reaction was quenched by the addition of aq. NH4Cl. Upon warming to room temperature, the mixture was extracted with EtOAc. The combined organic layers were dried (Na2SO4) and concentrated under reduced pressure. The resulting residue was purified by chromatography to afford 2-methylnicotinaldehyde 149 (2.18 g, 31percent).
31%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at -78℃; for 1 h;
Example 21. Synthesis of 2-(2-methylpyridin-3-yl)-N-(thiazol-2-yl)-[l,2,4]triazolo[l,5- a]pyridine-8-carboxamide (Compound 239):Step 1) Preparation of 2-methylnicotinaldehyde (89): To a solution of 3-bromo-2-methylpyridine (88; 10 g, 58.1 mmol) in THF (150 mL) was added n-BuLi (2.5 M, 25.6 mL) at -78 0C. The reaction mixture was stirred at this temperature for Ih. DMF (1.30 mL) was then added and the resulting reaction mixture was stirred for 1 h at -78 0C. The reaction was quenched by the addition of aq. NH4Cl. Upon warming to room temperature, the mixture was extracted with EtOAc. The combined organic layers were dried (Na2SO4) and concentrated under reduced pressure. The resulting residue was purified by chromatography to afford 2-methylnicotinaldehyde 89 (2.18 g, 31percent).
Reference: [1] Patent: WO2010/3048, 2010, A1, . Location in patent: Page/Page column 129
[2] Patent: WO2009/146358, 2009, A1, . Location in patent: Page/Page column 95
  • 3
  • [ 38749-79-0 ]
  • [ 253-69-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 7, p. 2989 - 3004
  • 4
  • [ 557-21-1 ]
  • [ 38749-79-0 ]
  • [ 1721-23-9 ]
YieldReaction ConditionsOperation in experiment
90% With tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 175℃; for 2 h; Microwave irradiation; Inert atmosphere 3-Bromo-2-methylpyridine (344 mg, 2 mmol), Zn(CN)2 (235 mg, 2 mmol) and Pd(PPh3)4 (75 mg, 0.06 mmol) were dissolved in DMF (5 mL). The mixture was vacuumed for N2 three times, The reaction solution was reacted in the microwave (175° C.) for 2 h under N 2 protection. After cooling, it was diluted with EtOAc (60 mL). After washing with saturated saline, dry over anhydrous sodium sulfate. Concentration by filtration and column chromatography of the residue provided the title compound as a white solid (212 mg, yield 90percent).
Reference: [1] Patent: CN103570683, 2018, B, . Location in patent: Paragraph 0619-0622
  • 5
  • [ 38749-79-0 ]
  • [ 1849-53-2 ]
Reference: [1] Patent: CN103570683, 2018, B,
  • 6
  • [ 124-38-9 ]
  • [ 38749-79-0 ]
  • [ 3222-56-8 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2006, vol. 49, # 9, p. 789 - 799
  • 7
  • [ 67-56-1 ]
  • [ 201230-82-2 ]
  • [ 38749-79-0 ]
  • [ 65719-09-7 ]
YieldReaction ConditionsOperation in experiment
93.6% at 80℃; for 16 h; A mixture of 3-bromo-2-methylpyridine (5.0 g, 29.0 mmol), Pd(dppf)C12 (2.1 g, 2.9 mmol) and Et3N (8.8 g, 87 mmol) in MeOH (250 mL) was stirred at 80 °C and 5OPsi under CO for 1 6h. Solid was then filtered out and the filtrate was concentrated. The residue was purified by column chromatography (PE:EA=5: 1) to give the desired product (4.1 g, 93.6percent). ‘H NMR (CD3OD, 400MHz) (ppm): 8.57 - 8.42 (m, 1H), 8.08 (d, 1=8.0 Hz, 1H),7.10 (dd, 1=4.8, 7.8 Hz, 1H), 3.81 (s, 3H), 2.73 (s, 3H). LCMS (mlz): 152.0 [M+H]+
Reference: [1] Patent: WO2015/200677, 2015, A2, . Location in patent: Paragraph 00787; 00788
  • 8
  • [ 109-06-8 ]
  • [ 38749-79-0 ]
YieldReaction ConditionsOperation in experiment
12% at 100℃; for 1.5 h; Reference Example 182 3-bromo-2-methylpyridine; 2-Methylpyridine (46.6 g) was added dropwise to aluminum chloride (200 g) and the mixture was stirred at 100° C. To a mixture was added dropwise bromine (40.0 g) at the same temperature over 1 hr, and the mixture was further stirred for 30 min. After cooling, the reaction mixture was poured into ice water, concentrated hydrochloric acid was added until the mixture was acidified. The obtained solution was washed with ethyl acetate, and the aqueous layer was basified with a 8 mol/L aqueous sodium hydroxide solution. After extraction with diethyl ether, the extract was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane-diethyl ether=10:1) to give the title compound as a colorless oil (yield 5.09 g, 12percent). 1H-NMR (CDCl3)δ: 2.67 (3H, s), 6.98-7.03 (1H, m), 7.78-7.82 (1H, m), 8.40-8.44 (1H, m).
Reference: [1] Patent: US2007/60623, 2007, A1, . Location in patent: Page/Page column 50
  • 9
  • [ 109-06-8 ]
  • [ 3430-13-5 ]
  • [ 38749-79-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 5, p. 871 - 880
[2] Journal of Labelled Compounds and Radiopharmaceuticals, 2006, vol. 49, # 9, p. 789 - 799
  • 10
  • [ 38749-79-0 ]
  • [ 52378-64-0 ]
Reference: [1] Patent: US2016/176882, 2016, A1,
[2] Patent: WO2017/221100, 2017, A1,
  • 11
  • [ 38749-79-0 ]
  • [ 116986-08-4 ]
Reference: [1] Patent: WO2015/200677, 2015, A2,
  • 12
  • [ 143-33-9 ]
  • [ 38749-79-0 ]
  • [ 122851-60-9 ]
Reference: [1] Synthesis, 1992, # 6, p. 528 - 530
  • 13
  • [ 38749-79-0 ]
  • [ 80957-68-2 ]
Reference: [1] Patent: WO2015/200677, 2015, A2,
  • 14
  • [ 38749-79-0 ]
  • [ 105-58-8 ]
  • [ 197376-41-3 ]
YieldReaction ConditionsOperation in experiment
37.7 g
Stage #1: With lithium hexamethyldisilazane In diethyl ether; hexane for 1 h;
Lithium hexamethyldisilazane (436 mL, 0.44 mmol, 1 M solution in hexanes) was dissolved in diethyl ether (1 L). Compound 26, 3-bromo-2-methylpyridine, (25.0 g, 0.14 mmol) was added. The solution was stuffed for 1 h. Diethyl carbonate (26.0 mL, 0.22 mol) was added and the solution was stirred overnight. The reaction solution was washed three times with half-saturated aqueous sodium chloride (3 x 250 mL) and dried with magnesium sulfate. The solvent was evaporated and the reminder was dissolved in hexanes (200 mL). The solution was filtered through silica pad (10 g), the pad was rinsed with additional hexanes (100 mL) and the solvent was evaporated. The remaining oil was stirred in high vacuum for 1 hour till there were no further bubbles visible. The product was a yellow liquid(37.7 g). LCMS: [M + Hj = 244.1.
37.7 g
Stage #1: With lithium hexamethyldisilazane In diethyl ether; hexane for 1 h;
[0117] Lithium hexamethyldisilazane (436 mL, 0.44 mmol, 1 M solution in hexanes) was dissolved in diethyl ether (1 L). Compound 1 , 3-bromo-2-methylpyridine, (25.0 g, 0.14 mmol) was added. The solution was stirred for 1 h. Diethyl carbonate (26.0 mL, 0.22 mol) was added and the solution was stirred overnight. The reaction solution was washed three times with half- saturated aqueous sodium chloride (3 χ 250 mL) and dried with magnesium sulfate. The solvent was evaporated and the reminder was dissolved in hexanes (200 mL). The solution was filtered through silica pad (10 g), the pad was rinsed with additional hexanes (100 mL) and the solvent was evaporated. The remaining oil was stirred in high vacuum for 1 hour till there were no further bubbles visible. The product was a yellow liquid (37.7 g). LCMS: [M + H]+ = 244.1.
Reference: [1] Organic Letters, 2016, vol. 18, # 8, p. 1713 - 1715
[2] Synthesis, 1997, # 8, p. 949 - 952
[3] Patent: WO2014/201127, 2014, A2, . Location in patent: Paragraph 00567
[4] Patent: WO2016/94710, 2016, A1, . Location in patent: Paragraph 0116-0117
  • 15
  • [ 38749-79-0 ]
  • [ 405174-97-2 ]
YieldReaction ConditionsOperation in experiment
63% With selenium(IV) oxide In 1,4-dioxane for 48 h; Reflux Dissolve 3-bromo-2-methylpyridine (258 mg, 1.5 mmol) in dioxane (5 mL) and add selenium dioxide while stirring (666 mg, 6.0 mmol), the mixture was refluxed for 48 h, allowed to cool, and the filtrate was concentrated. The residue was purified by column chromatography to give a pale yellow solid. (175 mg, 63percent yield).
55% With selenium(IV) oxide In 1,4-dioxane at 120℃; for 18 h; 3-Bromopicolinaldehyde (B5.1) (0362) A mixture of 3-bromo-2-methylpyridine (5 g, 29 mmol), SeO2 (17.5 mg, 116 mmol) in dioxane (70 mL) was heated to 120° C. and stirred for 18 h. The mixture was concentrated and purified by silica gel (PE:EA=4:1) to give the title compound (3 g, 55percent) as a white solid. LC-MS: [M+H]+=188.1.
55% With selenium(IV) oxide In 1,4-dioxane at 120℃; for 18 h; A mixture of 3-bromo-2-methylpyridine (5 g,2gmmol), SeQ2 (17.5 mg, ll6mmol) in dioxane (70 mL) was heated to 120°C andstirred for 18 h. The mixture was concentrated and purified by silica gel (PE:EA = 4:1)to give the title compound (3 g, 55percent) as a white solid. LC-MS: [M+H] = 188.1.
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 6, p. 1239 - 1245
[2] Patent: CN103570683, 2018, B, . Location in patent: Paragraph 0687; 0691-0694
[3] Patent: US2016/176882, 2016, A1, . Location in patent: Paragraph 0361; 0362
[4] Patent: WO2017/221100, 2017, A1, . Location in patent: Paragraph 00170
[5] Tetrahedron Letters, 2005, vol. 46, # 36, p. 6033 - 6036
[6] Patent: WO2012/177896, 2012, A1,
[7] Patent: WO2012/177893, 2012, A2,
[8] Journal of Medicinal Chemistry, 2014, vol. 57, # 7, p. 2989 - 3004
  • 16
  • [ 38749-79-0 ]
  • [ 899436-71-6 ]
Reference: [1] Patent: US2006/199817, 2006, A1, . Location in patent: Page/Page column 50
[2] British Journal of Pharmacology, 2018, vol. 175, # 17, p. 3470 - 3485
  • 17
  • [ 38749-79-0 ]
  • [ 155058-02-9 ]
Reference: [1] Patent: WO2015/200677, 2015, A2,
  • 18
  • [ 38749-79-0 ]
  • [ 754131-60-7 ]
YieldReaction ConditionsOperation in experiment
78% With N-Bromosuccinimide In tetrachloromethane for 4 h; Reflux A mixture of 6a (1 g, 5.8 mmol), benzoylperoxide (101 mg, 0.4 mmol) and NBS (1.1 g, 6.39 mmol) in CCI4 (58 mL) was heated under reflux for 4 h. The reaction mixture was cooled to rt, quenched with H20 and extracted with DCM (3 x 30 mL). The combined organic layers were dried over Na2S04, filtered and concentrated under reduced pressure. The residue was purified by CC on silica gel, eluting with PE:EA = 15:1 to afford 6b (1.1 g, 78percent yield) as a yellow oil.
30% With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane for 48 h; Inert atmosphere; Reflux Operations: 100g of compound 1 (3-bromo-2-methyl pyridine, TCI (Shanghai) Chemical Industry Co., Ltd.) wasdissolved in carbon tetrachloride. 155g of N-bromosuccinimide and 5g of benzoyl peroxide were added and refluxed for48h under nitrogen protection and cooled to filter off insoluble substances. After being added with an appropriate amountof ethyl acetate, the organic phase was washed with diluted hydrochloric acid once, then washed with a saturatedaqueous solution of sodium bicarbonate, and finally washed and extracted with saturated brine. The organic phase wasdried, filtered and distilled under reduced pressure to obtain a pale yellow oily substance, isolated by column chromatographyto obtain compound 2 (43g, yield 30percent). MS: m/z 251.8.
30% With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane for 48 h; Inert atmosphere; Reflux 100 g of compound 1 (3-bromo-2-methylpyridine, TCI (Shanghai) Chemical Industry Co., Ltd.) was dissolved in carbon tetrachloride. 155 g of N-bromosuccinimide and 5 g of benzoyl peroxide were added and refluxed for 48 h under nitrogen protection and cooled to filter off insoluble substances. After being added with an appropriate amount of ethyl acetate, the organic phase was washed with diluted hydrochloric acid once, then washed with a saturated aqueous solution of sodium bicarbonate, and finally washed and extracted with saturated brine. The organic phase was dried, filtered and distilled under reduced pressure to obtain a pale yellow oily substance, isolated by column chromatography to obtain compound 2 (43 g, yield 30percent). MS: m/z 251.8.
Reference: [1] Patent: WO2011/107248, 2011, A1, . Location in patent: Page/Page column 43
[2] Patent: EP2784077, 2014, A1, . Location in patent: Paragraph 0060; 0061
[3] Patent: US2014/343089, 2014, A1, . Location in patent: Paragraph 0066
[4] Patent: WO2009/51715, 2009, A1, . Location in patent: Page/Page column 33
[5] Patent: WO2004/98607, 2004, A1, . Location in patent: Page/Page column 51
[6] Patent: WO2011/56440, 2011, A1, . Location in patent: Page/Page column 31-32
  • 19
  • [ 73183-34-3 ]
  • [ 38749-79-0 ]
  • [ 1012084-56-8 ]
Reference: [1] Patent: US2009/143361, 2009, A1, . Location in patent: Page/Page column 52
[2] Patent: US2009/143367, 2009, A1, . Location in patent: Page/Page column 37
[3] Patent: US2010/120763, 2010, A1, . Location in patent: Page/Page column 47
[4] European Journal of Organic Chemistry, 2012, # 3, p. 595 - 603
  • 20
  • [ 38749-79-0 ]
  • [ 1173897-86-3 ]
Reference: [1] Patent: WO2015/17302, 2015, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 38749-79-0 ]

Bromides

Chemical Structure| 754131-60-7

[ 754131-60-7 ]

3-Bromo-2-(bromomethyl)pyridine

Similarity: 0.95

Chemical Structure| 27063-93-0

[ 27063-93-0 ]

3-Bromo-2,4-dimethylpyridine

Similarity: 0.91

Chemical Structure| 38749-81-4

[ 38749-81-4 ]

3-Bromo-2-ethylpyridine

Similarity: 0.89

Chemical Structure| 186593-43-1

[ 186593-43-1 ]

5-Amino-3-bromo-2-methylpyridine

Similarity: 0.88

Chemical Structure| 3430-31-7

[ 3430-31-7 ]

3-Bromo-2,6-dimethylpyridine

Similarity: 0.88

Related Parent Nucleus of
[ 38749-79-0 ]

Pyridines

Chemical Structure| 754131-60-7

[ 754131-60-7 ]

3-Bromo-2-(bromomethyl)pyridine

Similarity: 0.95

Chemical Structure| 27063-93-0

[ 27063-93-0 ]

3-Bromo-2,4-dimethylpyridine

Similarity: 0.91

Chemical Structure| 38749-81-4

[ 38749-81-4 ]

3-Bromo-2-ethylpyridine

Similarity: 0.89

Chemical Structure| 186593-43-1

[ 186593-43-1 ]

5-Amino-3-bromo-2-methylpyridine

Similarity: 0.88

Chemical Structure| 3430-31-7

[ 3430-31-7 ]

3-Bromo-2,6-dimethylpyridine

Similarity: 0.88